Cincinnati Enquirer: The Long Hard Road, Part 3
UC medical students eye underserved communities
The Cincinnati Enquirer devoted a special section to examining poverty in the Tristate and the inability of residents to achieve upward economic mobility. Part of the section looked at medicine and how while gender equality has improved in medical education, economic diversity lags. Students of color still face an upheld battle in attending medical school. Their presence is crucial in helping to fuel the pipeline for physicians of color serving communities. Three medical students at the University of Cincinnati (UC) College of Medicine—Fernando Blank, Adam Butler and Halimat Olaniyan—shared their thoughts about serving underserved communities. Students of color represented 23 percent of the 185 new medical students at UC College of Medicine, the largest share ever in the school’s history.
Read the special section online.
Learn more about this year diverse class of medical students.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.